SynapCell sponsors the US East CoAst CNS Therapeutics Xchange 2021
May 24-27 2021
Round Table at a glance
Join top experts from Academia, Biotech and Pharmaceutical companies to push our understanding of brain oscillations as the next big thing in translational CNS drug discovery during a Round table at the US East Coast CNS Therapeutic Xchange 2021.
Session Title: The Current Role and Application of EEG in CNS Drug Discovery
Explore the translational aspects for both animal to human and preclinical to clinical
Discuss, where are the current limits of EEG applications?
What novel solutions do we need to develop with EEG in the near future?
We look forward to discussing with you there!
Featured PANELLISTS and moderators
Corinne ROUCARD, PhD
Chief Executive Officer
Synapcell
“In 2005 I co-founded and became C.E.O. at SynapCell, a drug discovery-focused CRO specialized in CNS disorders. Neuropsychiatric and neurodegenerative disorders represent a major burden today, and their incidence will continue to grow. It is our duty to assist the discovery of new treatments for patients, and I always keep in mind the need to develop innovative drug discovery solutions that are as translational as possible and inspired by a bed to benchside strategy. At SynapCell I am responsible for customer relations, and this mission allows me to actively participate in international networks, while also building strong relationships with our clients.”
Venceslas DUVEAU, PhD
Head of Science
Synapcell
“I am a neuroscientist with a strong interest and over 10 years of experience in drug discovery and brain disorders such as epilepsy, Parkinson’s and Alzheimer’s diseases. As SynapCell’s Head of science, I am at the cutting edge of Neuroscience research through the management and development of research programs for customers or for internal R&D projects.”
Can’t make it this time? So let’s have a call!